PURE Bioscience Board Appoints John J. Carbone, MD to Board of...(ard industry and consumer use of green ...)

Date:3/9/2009

ard industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

    PURE Investor Contact:               PURE Media Contact:
    Paul G. Henning, Vice President      Michael Gallo
    Cameron Associates                   Gutenberg Communications
    (212) 554-5462                       (212) 2
'/>"/>
SOURCE  PURE Bioscience
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 
Related biology technology :

1. S*BIO Receives BioSpectrum Editors Choice, Emerging BioScience Company of Singapore Award
2. Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008
3. Pressure BioSciences, Inc. to Present at the EdgeWater Research Partners Spring 2009 Micro/Small-Cap Investor Conference
4. EUCODIS Bioscience and Lohmann Animal Health Announce Achievement of Major Development Milestone
5. INVO Bioscience Completes Reverse Merger
6. Speid & Associates Partners With Genizon BioSciences to Reduce Attrition Rates of New Drug Compounds
7. Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences
8. Pressure BioSciences, Inc. Announces Completion of Private Placement
9. YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
10. On Third Anniversary, Compendia Bioscience Announces Continued Revenue Growth, Major Long-Term Customer Contracts and Forecasts Profitability
11. Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results